Medical News

RSS

Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

Ligon Discovery, the innovator of Small Molecule Microarray technology, today announced that it has partnered with Bayer Schering Pharma AG, Germany, to apply its proprietary Small Molecule Microarray screening platform (SMM) to discover potential first-in-class drug candidates for new disease targets.

29 Sep 2010

Pulmokine receives NIH SBIR grants to develop novel treatments for PAH

YM BioSciences Inc., today reported that Pulmokine Inc. (Slingerlands, New York), a licensee of several small molecule compounds from YM, has been awarded two National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grants. The grants, totaling more than US$650,000, are Phase I awards to develop novel treatments for Pulmonary Arterial Hypertension (PAH).

29 Sep 2010

Quick-Med to present abstracts on antimicrobial technologies at Clinical Symposium

Quick-Med Technologies, Inc.a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today its NIMBUS and Stay Fresh antimicrobial technologies will be highlighted at the 2010 Clinical Symposium on Advances in Skin and Wound Care, to be held in Orlando, Florida from September 30 – October 3, 2010.

29 Sep 2010

New program offers options for fertility preservation in children with cancer

It is estimated that 1 in 500 children will be diagnosed with a form of childhood cancer. Fortunately, with the use of aggressive treatment modalities, more than 75% of these children will be cured. Therefore, many of these children and parents are looking beyond the cancer at important quality of life issues and guiding their treatments to assure "normal" post-cancer survivorship.

29 Sep 2010

XOMA completes patient enrollment in XOMA 052 Phase 2a trial

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that patient enrollment was recently completed for the company's Phase 2a trial of XOMA 052 in patients with Type 2 diabetes.

29 Sep 2010

Quidel receives FDA clearance for QuickVue RSV 10 immunoassay test

Quidel Corporation, a leading provider of rapid diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the sale of its QuickVue RSV 10, a lateral flow immunoassay test for the qualitative detection of acute respiratory syncytial virus (RSV) infections.

29 Sep 2010

First Edition: September 29, 2010

In today's headlines, reports about the continuing politics surrounding the health overhaul, as both parties vie for the loyalty of older voters and First Lady Michelle Obama steps up efforts to promote the new law.

29 Sep 2010

NIH trial selects Inovio's PENNVAX-G DNA vaccine candidate to evaluate HIV-1 prevalent

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa, and South America.

29 Sep 2010

Significant progress made universally in increasing access to HIV/AIDS services: Report

Significant progress has been made in several low- and middle-income countries in increasing access to HIV/AIDS services, according to a new report released today. The report Towards universal access by WHO, the United Nations Children's Fund and the Joint United Nations Programme on HIV/AIDS is the fourth annual report for tracking progress made in achieving the 2010 target of providing universal access to HIV prevention, treatment and care.

29 Sep 2010

Researchers primed to contribute next phase in search and discovery: Elsevier survey

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today released highlights from a new survey that reveals researchers around the globe are not only ready for the next phase in search and discovery, but also prepared to actively contribute to making it a reality.

29 Sep 2010

Cancer-causing mutations have minimum effect on tumor growth: Research

Individual cancer causing mutations have a minute effect on tumor growth, increasing the rate of cell division by just 0.4 percent on average, according to new mathematical modeling by scientists at Harvard University, Johns Hopkins University, and other institutions.

29 Sep 2010

Report shows continuing progress in scaling up global HIV/AIDS interventions

The 2010 report on universal access to HIV prevention, care and treatment released today by WHO, UNAIDS, and UNICEF shows continuing progress in scaling up global HIV/AIDS interventions.

29 Sep 2010

Sysmex to supply medical hematology analyzers to USAMMA

Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced that the company has been awarded a BPA Equipment purchase contract agreement. The contract was issued by USA Medical Research ACQ Activity for the U.S. Army Medical Material Agency (USAMMA).

From Sysmex America, Inc. 29 Sep 2010

Studies on complexities of male and female attractiveness

Scientists in Australia and Hong Kong have conducted a comprehensive study to discover how different body measurements correspond with ratings of female attractiveness. The study, published in the Journal of Evolutionary Biology, found that across cultural divides young, tall and long armed women were considered the most attractive.

29 Sep 2010

Inability to access EMRs at time of need a prime concern among patients

As the healthcare industry rushes to implement electronic medical records (EMRs) in order to increase efficiency and prevent errors, data shows that less than 1 in 10 Americans utilize electronic records. However, when asked about their primary concerns regarding medical records, patients' top response is that they won't be able to access their records when they need them.

29 Sep 2010

Patients' right to be involved in own medical care

Twelve years ago, then 28-year-old graduate student Brian Zikmund-Fisher was forced into the toughest choice of his life: Die from a blood disorder within a few years or endure a bone marrow transplant that could cure him or kill him in weeks.

29 Sep 2010

Researchers identify gene activator that allows stem cells to transform any type of cell

Emerging Healthcare Solutions, Inc. was energized Monday by news that researchers in North Carolina may have identified the gene activator that allows stem cells to reproduce and become any type of cell in the body.

29 Sep 2010

Increased drug use linked to father's incarceration

In a recently published study in the journal Addiction, researchers from Bowling Green State University report evidence of an association between father's incarceration and substantially elevated risks for illegal drug use in adolescence and early adulthood.

29 Sep 2010

Walgreen selects Accertify's Interceptas platform for online fraud prevention

The Interceptas® platform by Accertify® has been selected by Walgreen Co. for preventing online credit card fraud in its e-commerce business.

29 Sep 2010

U-M experts clear confusion over mammography screening controversy

A year after a government panel revised its recommendations for breast cancer screening, many professional organizations have not followed suit.

29 Sep 2010

Medical News

Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

Pulmokine receives NIH SBIR grants to develop novel treatments for PAH

Quick-Med to present abstracts on antimicrobial technologies at Clinical Symposium

New program offers options for fertility preservation in children with cancer

XOMA completes patient enrollment in XOMA 052 Phase 2a trial

Quidel receives FDA clearance for QuickVue RSV 10 immunoassay test

First Edition: September 29, 2010

NIH trial selects Inovio's PENNVAX-G DNA vaccine candidate to evaluate HIV-1 prevalent

Significant progress made universally in increasing access to HIV/AIDS services: Report

Researchers primed to contribute next phase in search and discovery: Elsevier survey

Cancer-causing mutations have minimum effect on tumor growth: Research

Report shows continuing progress in scaling up global HIV/AIDS interventions

Sysmex to supply medical hematology analyzers to USAMMA

Studies on complexities of male and female attractiveness

Inability to access EMRs at time of need a prime concern among patients

Patients' right to be involved in own medical care

Researchers identify gene activator that allows stem cells to transform any type of cell

Increased drug use linked to father's incarceration

Walgreen selects Accertify's Interceptas platform for online fraud prevention

U-M experts clear confusion over mammography screening controversy

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News